Journal
CANCER LETTERS
Volume 246, Issue 1-2, Pages 201-209Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2006.02.015
Keywords
xanthohumol; prostate cancer; apoptosis; NF-kappaB; diet and cancer
Categories
Funding
- NCI NIH HHS [CA107693] Funding Source: Medline
- NIEHS NIH HHS [P30 ES00210] Funding Source: Medline
Ask authors/readers for more resources
There is increasing evidence that certain natural compounds found in plants may be useful as cancer chemopreventive or chemotherapeutic agents. Limited in vitro studies indicate that several prenylated flavonoids present in the hop plant (Humulus lupulus) possess anticarcinogenic properties. The purpose of this study was to investigate the anti-tumorigenic effects of xanthohumol (XN), the major prenylflavonoid in hops, on prostate cancer and benign prostate hyperplasia. BPH-1 and PC3 cell lines were used in our study to represent both non-tumorigenic hyperplasia and malignant prostate cancer. In both BPH-1 and PC3 cells, XN and its oxidation product, XAL, decreased cell viability in a dose dependent manner (2.5-20 mu M) as determined by MTT assay and caused an increase in the formation of early and late apoptotic cells as determined by Annexin V staining and multicaspase assays. XN and its oxygenated derivative also induced cell cycle changes in both cells lines, seen in an elevated sub G1 peak at 48 h treatment. Western blot analysis was performed to confirm the activation of proapoptotic proteins, Bax and p53. XN and its derivative caused decreased activation of NF kappa B. This work suggests that XN and its oxidation product, XAL, may be potentially useful as a chernopreventive agent during prostate hyperplasia and prostate carcinogenesis, acting via induction of apoptosis and down-regulation of NF kappa B activation in BPH-1 cells. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available